Fiorentino, F., & Di Rienzo, P. (2023). Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy. Global and Regional Health Technology Assessment, 10(1), 29–39. https://doi.org/10.33393/grhta.2023.2507